Hospital Mae de Deus- Site Number : 0760003

Porto Alegre, Rio Grande do Sul 90880-480

1 studies enrolling now · 3 studies all time

What they study most

Plasma Cell Myeloma, Plasma Cell Myeloma Recurrent

Studies at this site

• International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab — Enrolling by invitation
• Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory Multiple Myeloma Patients — Completed
• SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM — Running, not enrolling